Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

Dec 9, 2016

30339_dirs_2016-12-09_4656433a-5da5-4e84-b909-fbf489a1bd93.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-12-08

Reporting Person: ZENNER PATRICK J (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-08 Common Stock P 332.00 $84.528 Acquired 51831.1253 Direct

Footnotes

F1: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $84.52 to $84.54, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.